The Current Ratio of Seres Therapeutics, Inc. (MCRB) is
2.56.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
2.56
|
| 2024-12-31 |
0.94
|
| 2023-12-31 |
1.78
|
| 2022-12-31 |
2.28
|
| 2021-12-31 |
3.69
|
| 2020-12-31 |
5.79
|
| 2019-12-31 |
2.18
|
| 2018-12-31 |
2.20
|
| 2017-12-31 |
4.90
|
| 2016-12-31 |
6.51
|
| Ticker |
Name |
Value |
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
DMTK
|
DermTech Inc
|
4.59
|
|
KRON
|
Kronos Bio LLC
|
7.54
|
|
KURA
|
Kura Oncology, Inc.
|
6.06
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
MYOV
|
Myovant Sciences Ltd
|
1.95
|
|
SBTX
|
Silverback Therapeutics Inc
|
17.56
|
|
SGMO
|
Sangamo Therapeutics Inc
|
0.84
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
FPRX
|
Five Prime Therapeutics Inc
|
13.18
|
|
NKTX
|
Nkarta, Inc.
|
12.69
|
|
OCGN
|
Ocugen, Inc.
|
1.06
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
9.95
|
|
REPL
|
Replimune Group, Inc.
|
4.79
|
|
VBIV
|
VBI Vaccines Inc
|
0.48
|
|
BCAB
|
Bioatla Inc
|
0.37
|
|
INO
|
Inovio Pharmaceuticals Inc
|
1.40
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
CCCC
|
C4 Therapeutics, Inc.
|
7.81
|
|
GBIO
|
Generation Bio Co
|
5.50
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
KRYS
|
Krystal Biotech, Inc.
|
9.95
|
|
ALEC
|
Alector, Inc.
|
3.83
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
7.02
|
|
PAND
|
Pandion Therapeutics Inc
|
2.84
|
|
PMVP
|
Pmv Pharmaceuticals, Inc
|
10.09
|
|
ZYME
|
Zymeworks Inc.
|
5.88
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
RUBY
|
Rubius Therapeutics Inc
|
2.56
|
|
CYTK
|
Cytokinetics, Incorporated
|
4.53
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
ADCT
|
Adc Therapeutics Ltd
|
4.37
|
|
ALVR
|
Allovir Inc
|
22.63
|
|
AMTI
|
Applied Molecular Transport Inc.
|
4.24
|
|
CGEM
|
Cullinan Therapeutics, Inc.
|
10.25
|